Cambodia vs Colombia: Death rate from cancer
Cambodia
88.93 deaths per 100,000 people
in 2021
Colombia
88.96 deaths per 100,000 people
in 2021
Cambodia rank
102nd
Colombia rank
101st
Death rate from cancer over time
- Cambodia
- Colombia
How they compare
Colombia currently reports 88.96 deaths per 100,000 people against 88.93 deaths per 100,000 people in Cambodia, a difference of 0.03 deaths per 100,000 people.
Across all 22 years both countries report, Colombia has been ahead every year.
Cambodia ranks 102nd and Colombia ranks 101st of 194 countries.
Colombia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | Colombia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.3 deaths per 100,000 people | 73.93 deaths per 100,000 people | 10.63 deaths per 100,000 people | Colombia |
| 2010s | 78.04 deaths per 100,000 people | 84.1 deaths per 100,000 people | 6.06 deaths per 100,000 people | Colombia |
| 2020s | 89.5 deaths per 100,000 people | 89.91 deaths per 100,000 people | 0.405 deaths per 100,000 people | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Cambodia or Colombia?
- Colombia, at 88.96 deaths per 100,000 people against 88.93 deaths per 100,000 people in Cambodia as of 2021.
- What is the difference in death rate from cancer between Cambodia and Colombia?
- 0.03 deaths per 100,000 people, with Colombia ahead.
- How many years of comparable data are there for Cambodia and Colombia?
- 22 years are reported by both, from 2000 to 2021.
- How do Cambodia and Colombia rank globally for death rate from cancer?
- Cambodia ranks 102nd and Colombia ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.